ID   NEK9_HUMAN              Reviewed;         979 AA.
AC   Q8TD19; Q52LK6; Q8NCN0; Q8TCY4; Q9UPI4; Q9Y6S4; Q9Y6S5; Q9Y6S6;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   02-NOV-2010, entry version 98.
DE   RecName: Full=Serine/threonine-protein kinase Nek9;
DE            EC=2.7.11.1;
DE   AltName: Full=Nercc1 kinase;
DE   AltName: Full=Never in mitosis A-related kinase 9;
DE            Short=NimA-related protein kinase 9;
DE   AltName: Full=NimA-related kinase 8;
DE            Short=Nek8;
GN   Name=NEK9; Synonyms=KIAA1995, NEK8, NERCC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, PROTEIN SEQUENCE OF
RP   61-70; 318-327; 331-352 AND 511-530, MUTAGENESIS OF THR-210 AND
RP   THR-214, AND VARIANT HIS-429.
RC   TISSUE=Dendritic cell, and Fibroblast;
RX   MEDLINE=21975258; PubMed=11864968; DOI=10.1074/jbc.M108662200;
RA   Holland P.M., Milne A., Garka K., Johnson R.S., Willis C., Sims J.E.,
RA   Rauch C.T., Bird T.A., Virca G.D.;
RT   "Purification, cloning, and characterization of Nek8, a novel NIMA-
RT   related kinase, and its candidate substrate Bicd2.";
RL   J. Biol. Chem. 277:16229-16240(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, PARTIAL PROTEIN
RP   SEQUENCE, AND MUTAGENESIS OF LYS-81.
RX   MEDLINE=22095334; PubMed=12101123; DOI=10.1101/gad.972202;
RA   Roig J., Mikhailov A., Belham C., Avruch J.;
RT   "Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and
RT   regulates mitotic progression.";
RL   Genes Dev. 16:1640-1658(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-429.
RC   TISSUE=Brain;
RX   MEDLINE=22051173; PubMed=12056414; DOI=10.1093/dnares/9.2.47;
RA   Ohara O., Nagase T., Mitsui G., Kohga H., Kikuno R., Hiraoka S.,
RA   Takahashi Y., Kitajima S., Saga Y., Koseki H.;
RT   "Characterization of size-fractionated cDNA libraries generated by the
RT   in vitro recombination-assisted method.";
RL   DNA Res. 9:47-57(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22459283; PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH SSRP1 AND SUPT16H, SUBCELLULAR LOCATION,
RP   AND PHOSPHORYLATION AT THR-210.
RX   PubMed=14660563; DOI=10.1074/jbc.M311477200;
RA   Tan B.C.-M., Lee S.-C.;
RT   "Nek9, a novel FACT-associated protein, modulates interphase
RT   progression.";
RL   J. Biol. Chem. 279:9321-9330(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-869, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; THR-333; THR-358
RP   AND SER-868, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [9]
RP   INTERACTION WITH NEK6.
RX   PubMed=19001501; DOI=10.1242/jcs.035360;
RA   Rapley J., Nicolas M., Groen A., Regue L., Bertran M.T., Caelles C.,
RA   Avruch J., Roig J.;
RT   "The NIMA-family kinase Nek6 phosphorylates the kinesin Eg5 at a novel
RT   site necessary for mitotic spindle formation.";
RL   J. Cell Sci. 121:3912-3921(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-13; SER-16;
RP   SER-20; SER-29; SER-76; THR-254; SER-331; SER-332; SER-741; SER-750;
RP   SER-793; SER-827; SER-829; SER-836; SER-868; THR-886; SER-944 AND
RP   SER-978, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-333, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-333, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-13; SER-16;
RP   SER-20; SER-28; SER-29; TYR-52; SER-76; SER-203; TYR-205; THR-254;
RP   SER-331; SER-332; THR-333; THR-335; SER-357; THR-358; SER-413;
RP   SER-735; SER-749; SER-750; SER-793; THR-795; SER-801; SER-827;
RP   SER-829; SER-832; SER-836; SER-838; SER-868; SER-869; THR-886;
RP   SER-944; SER-974 AND SER-978, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-333, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-731, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-429; THR-828 AND SER-870.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Pleiotropic regulator of mitotic progression,
CC       participating in the control of spindle dynamics and chromosome
CC       separation. Phosphorylates different histones, myelin basic
CC       protein, beta-casein, and BICD2. Phosphorylates histone H3 on
CC       serine and threonine residues and beta-casein on serine residues.
CC       Important for G1/S transition and S phase progression.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated during mitosis by intramolecular
CC       autophosphorylation. Activity and autophosphorylation is activated
CC       by manganese >> magnesium ions. Sensitive to increasing
CC       concentration of detergents. It is not cell-cycle regulated but
CC       activity is higher in G0-arrested cells.
CC   -!- SUBUNIT: Homodimer. Binds to Ran GTPase. Has a greater affinity
CC       for Ran-GDP over Ran-GTP. Interacts with NEK6, NEK7 and BICD2.
CC       Interacts with SSRP1 and SUPT16H, the 2 subunits of the FACT
CC       complex.
CC   -!- INTERACTION:
CC       P60520:GABARAPL2; NbExp=1; IntAct=EBI-1044009, EBI-720116;
CC       Q9HC98:NEK6; NbExp=1; IntAct=EBI-1044009, EBI-740364;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Most abundant in heart, liver, kidney and
CC       testis. Also expressed in smooth muscle cells and fibroblasts.
CC   -!- DEVELOPMENTAL STAGE: Expression varied mildly across the cell
CC       cycle, with highest expression observed in G1 and stationary-phase
CC       cells.
CC   -!- DOMAIN: Dimerizes through its coiled-coil domain.
CC   -!- PTM: Autophosphorylated on serine and threonine residues. When
CC       complexed with FACT, exhibits markedly elevated phosphorylation on
CC       Thr-210. During mitosis, not phosphorylated on Thr-210.
CC       Phosphorylated by CDK1 in vitro.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 6 RCC1 repeats.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD31936.1; Type=Erroneous gene model prediction;
CC       Sequence=BAC02704.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY048580; AAL05428.1; -; mRNA.
DR   EMBL; AY080896; AAL87410.1; -; mRNA.
DR   EMBL; AB082526; BAC02704.1; ALT_INIT; mRNA.
DR   EMBL; AC007055; AAD31936.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC007055; AAD31938.1; -; Genomic_DNA.
DR   EMBL; AC007055; AAD31939.1; -; Genomic_DNA.
DR   EMBL; AC007055; AAD31940.1; -; Genomic_DNA.
DR   EMBL; BC009336; AAH09336.2; -; mRNA.
DR   EMBL; BC093881; AAH93881.1; -; mRNA.
DR   EMBL; BC112101; AAI12102.1; -; mRNA.
DR   IPI; IPI00301609; -.
DR   RefSeq; NP_149107.4; -.
DR   UniGene; Hs.7200; -.
DR   ProteinModelPortal; Q8TD19; -.
DR   SMR; Q8TD19; 51-311, 342-726.
DR   IntAct; Q8TD19; 14.
DR   MINT; MINT-2984282; -.
DR   STRING; Q8TD19; -.
DR   PhosphoSite; Q8TD19; -.
DR   PeptideAtlas; Q8TD19; -.
DR   PRIDE; Q8TD19; -.
DR   Ensembl; ENST00000238616; ENSP00000238616; ENSG00000119638.
DR   GeneID; 91754; -.
DR   KEGG; hsa:91754; -.
DR   UCSC; uc001xrl.1; human.
DR   CTD; 91754; -.
DR   GeneCards; GC14M075548; -.
DR   H-InvDB; HIX0202044; -.
DR   HGNC; HGNC:18591; NEK9.
DR   HPA; HPA001405; -.
DR   MIM; 609798; gene.
DR   PharmGKB; PA38593; -.
DR   eggNOG; prNOG13112; -.
DR   HOVERGEN; HBG039572; -.
DR   InParanoid; Q8TD19; -.
DR   OMA; PGKTHTA; -.
DR   OrthoDB; EOG9HHRN4; -.
DR   PhylomeDB; Q8TD19; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 77443; -.
DR   ArrayExpress; Q8TD19; -.
DR   Bgee; Q8TD19; -.
DR   CleanEx; HS_NEK8; -.
DR   CleanEx; HS_NEK9; -.
DR   Genevestigator; Q8TD19; -.
DR   GermOnline; ENSG00000119638; Homo sapiens.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007067; P:mitosis; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR000408; Reg_chr_condens.
DR   InterPro; IPR009091; Reg_csome_cond/b-lactamase_inh.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:2.130.10.30; Reg_csome_cond/b-lactamase_inh; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00415; RCC1; 4.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50985; RCC1/BLIP-II; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00625; RCC1_1; FALSE_NEG.
DR   PROSITE; PS00626; RCC1_2; FALSE_NEG.
DR   PROSITE; PS50012; RCC1_3; 6.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cell division; Coiled coil;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Kinase;
KW   Magnesium; Metal-binding; Mitosis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Repeat; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    979       Serine/threonine-protein kinase Nek9.
FT                                /FTId=PRO_0000086435.
FT   DOMAIN       52    308       Protein kinase.
FT   REPEAT      388    444       RCC1 1.
FT   REPEAT      445    498       RCC1 2.
FT   REPEAT      499    550       RCC1 3.
FT   REPEAT      551    615       RCC1 4.
FT   REPEAT      616    668       RCC1 5.
FT   REPEAT      669    726       RCC1 6.
FT   NP_BIND      58     66       ATP (By similarity).
FT   REGION      732    891       Interaction with NEK6.
FT   COILED      892    939       Potential.
FT   COMPBIAS    752    760       Poly-Gly.
FT   COMPBIAS    765    888       Pro/Ser/Thr-rich.
FT   ACT_SITE    176    176       Proton acceptor (By similarity).
FT   BINDING      81     81       ATP.
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES      13     13       Phosphoserine.
FT   MOD_RES      16     16       Phosphoserine.
FT   MOD_RES      20     20       Phosphoserine.
FT   MOD_RES      28     28       Phosphoserine.
FT   MOD_RES      29     29       Phosphoserine.
FT   MOD_RES      52     52       Phosphotyrosine.
FT   MOD_RES      76     76       Phosphoserine.
FT   MOD_RES     203    203       Phosphoserine.
FT   MOD_RES     205    205       Phosphotyrosine.
FT   MOD_RES     210    210       Phosphothreonine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     254    254       Phosphothreonine.
FT   MOD_RES     331    331       Phosphoserine.
FT   MOD_RES     332    332       Phosphoserine.
FT   MOD_RES     333    333       Phosphothreonine.
FT   MOD_RES     335    335       Phosphothreonine.
FT   MOD_RES     357    357       Phosphoserine.
FT   MOD_RES     358    358       Phosphothreonine.
FT   MOD_RES     413    413       Phosphoserine.
FT   MOD_RES     731    731       N6-acetyllysine.
FT   MOD_RES     735    735       Phosphoserine.
FT   MOD_RES     741    741       Phosphoserine.
FT   MOD_RES     749    749       Phosphoserine.
FT   MOD_RES     750    750       Phosphoserine.
FT   MOD_RES     793    793       Phosphoserine.
FT   MOD_RES     795    795       Phosphothreonine.
FT   MOD_RES     801    801       Phosphoserine.
FT   MOD_RES     827    827       Phosphoserine.
FT   MOD_RES     829    829       Phosphoserine.
FT   MOD_RES     832    832       Phosphoserine.
FT   MOD_RES     836    836       Phosphoserine.
FT   MOD_RES     838    838       Phosphoserine.
FT   MOD_RES     868    868       Phosphoserine.
FT   MOD_RES     869    869       Phosphoserine.
FT   MOD_RES     886    886       Phosphothreonine.
FT   MOD_RES     944    944       Phosphoserine.
FT   MOD_RES     974    974       Phosphoserine.
FT   MOD_RES     978    978       Phosphoserine.
FT   VARIANT     429    429       R -> H (in dbSNP:rs10146482).
FT                                /FTId=VAR_027900.
FT   VARIANT     828    828       P -> T (in dbSNP:rs36014869).
FT                                /FTId=VAR_040926.
FT   VARIANT     870    870       P -> S (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_040927.
FT   MUTAGEN      81     81       K->M: Loss of activity and
FT                                autophosphorylation.
FT   MUTAGEN     210    210       T->A: Significant reduction of
FT                                autophosphorylation.
FT   MUTAGEN     214    214       T->A: No effect on autophosphorylation.
FT   CONFLICT    351    351       V -> I (in Ref. 2; AAL87410).
FT   CONFLICT    967    967       W -> G (in Ref. 2; AAL87410).
SQ   SEQUENCE   979 AA;  107168 MW;  8583FDDE599324A2 CRC64;
     MSVLGEYERH CDSINSDFGS ESGGCGDSSP GPSASQGPRA GGGAAEQEEL HYIPIRVLGR
     GAFGEATLYR RTEDDSLVVW KEVDLTRLSE KERRDALNEI VILALLQHDN IIAYYNHFMD
     NTTLLIELEY CNGGNLYDKI LRQKDKLFEE EMVVWYLFQI VSAVSCIHKA GILHRDIKTL
     NIFLTKANLI KLGDYGLAKK LNSEYSMAET LVGTPYYMSP ELCQGVKYNF KSDIWAVGCV
     IFELLTLKRT FDATNPLNLC VKIVQGIRAM EVDSSQYSLE LIQMVHSCLD QDPEQRPTAD
     ELLDRPLLRK RRREMEEKVT LLNAPTKRPR SSTVTEAPIA VVTSRTSEVY VWGGGKSTPQ
     KLDVIKSGCS ARQVCAGNTH FAVVTVEKEL YTWVNMQGGT KLHGQLGHGD KASYRQPKHV
     EKLQGKAIRQ VSCGDDFTVC VTDEGQLYAF GSDYYGCMGV DKVAGPEVLE PMQLNFFLSN
     PVEQVSCGDN HVVVLTRNKE VYSWGCGEYG RLGLDSEEDY YTPQKVDVPK ALIIVAVQCG
     CDGTFLLTQS GKVLACGLNE FNKLGLNQCM SGIINHEAYH EVPYTTSFTL AKQLSFYKIR
     TIAPGKTHTA AIDERGRLLT FGCNKCGQLG VGNYKKRLGI NLLGGPLGGK QVIRVSCGDE
     FTIAATDDNH IFAWGNGGNG RLAMTPTERP HGSDICTSWP RPIFGSLHHV PDLSCRGWHT
     ILIVEKVLNS KTIRSNSSGL SIGTVFQSSS PGGGGGGGGG EEEDSQQESE TPDPSGGFRG
     TMEADRGMEG LISPTEAMGN SNGASSSCPG WLRKELENAE FIPMPDSPSP LSAAFSESEK
     DTLPYEELQG LKVASEAPLE HKPQVEASSP RLNPAVTCAG KGTPLTPPAC ACSSLQVEVE
     RLQGLVLKCL AEQQKLQQEN LQIFTQLQKL NKKLEGGQQV GMHSKGTQTA KEEMEMDPKP
     DLDSDSWCLL GTDSCRPSL
//
